BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37980221)

  • 41. Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women.
    Tan Y; Mai H; Huang Z; Zhang L; Li C; Wu S; Huang H; Tang W; Liu Y; Jiang K
    BMC Med Imaging; 2021 Mar; 21(1):48. PubMed ID: 33706695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.
    Li X; Jiang N; Zhang C; Luo X; Zhong P; Fang J
    Cancer Imaging; 2021 Mar; 21(1):29. PubMed ID: 33712070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast.
    El Khouli RH; Macura KJ; Barker PB; Habba MR; Jacobs MA; Bluemke DA
    J Magn Reson Imaging; 2009 Nov; 30(5):999-1004. PubMed ID: 19856413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetic analysis of lesions without mass effect on breast MRI using manual and computer-assisted methods.
    Vag T; Baltzer PA; Dietzel M; Zoubi R; Gajda M; Camara O; Kaiser WA
    Eur Radiol; 2011 May; 21(5):893-8. PubMed ID: 21063709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang C; Wei W; Santiago L; Whitman G; Dogan B
    Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.
    Fan X; Medved M; Karczmar GS; Yang C; Foxley S; Arkani S; Recant W; Zamora MA; Abe H; Newstead GM
    Magn Reson Imaging; 2007 Jun; 25(5):593-603. PubMed ID: 17540270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of malignant and benign breast lesions using magnetization transfer imaging and dynamic contrast-enhanced MRI.
    Heller SL; Moy L; Lavianlivi S; Moccaldi M; Kim S
    J Magn Reson Imaging; 2013 Jan; 37(1):138-45. PubMed ID: 23097239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic role of dynamic contrast-enhanced magnetic resonance imaging in differentiating breast lesions.
    Dakhil HA; Easa AM; Hussein AY; Bustan RA; Najm HS
    J Popul Ther Clin Pharmacol; 2022; 29(2):e88-e94. PubMed ID: 35848201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC).
    Ohashi A; Kataoka M; Kanao S; Iima M; Murata K; Weiland E; Onishi N; Kawai M; Toi M; Togashi K
    Eur J Radiol; 2019 Sep; 118():285-292. PubMed ID: 31324411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
    Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
    Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of breast lesion using T
    Thakran S; Gupta PK; Kabra V; Saha I; Jain P; Gupta RK; Singh A
    Diagn Interv Imaging; 2018 Oct; 99(10):633-642. PubMed ID: 29910171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Jiang Y; Edwards AV; Newstead GM
    Radiology; 2021 Jan; 298(1):38-46. PubMed ID: 33078996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.